Ontak and bradycardia Patient Reports February 13, 2012

Ontak Side Effects Report #4932812-X
Ontak side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2006. Male patient, 70 years of age, weighting 212.0 lb, was diagnosed with t-cell lymphoma and was treated with Ontak. After drug was administered, patient experienced the following side effects: blood pressure immeasurable, bradycardia, erythema, eye rolling, feeling abnormal, infusion related reaction, loss of consciousness, miosis, moaning. Ontak dosage: 855 MG Q D X 5D Q 3 WEEKS IV. During the same period patient was treated with TYLENOL, DECADRON SRC, ZOFRAN, CENTRUM SILVER, CIPRO, SINGULAIR. Patient died on 02/27/2006.

Ontak Side Effects Report #5427734-4
Ontak side effect was reported by a Pharmacist from UNITED STATES on Aug 14, 2007. Female patient, 66 years of age, weighting 134.5 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: bradycardia, capillary leak syndrome, electromechanical dissociation, haemolysis, hypotension, myocardial infarction, rhabdomyolysis, tumour lysis syndrome, ventricular fibrillation. Ontak dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, CYTOXAN, PREDNISONE, LIPITOR, LISINOPRIL, HYDROCHLOROTHIAZIDE. Patient died on 08/06/2007.

Ontak Side Effects Report #5448922-7
Ontak side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 66 years of age, weighting 134.5 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: acute myocardial infarction, blood lactic acid increased, bradycardia, capillary leak syndrome, cardiac arrest , electromechanical dissociation, haemolysis, hypotension, lymphocyte percentage decreased. Ontak dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBIVIN, CYTOXAN, PREDNISONE, LIPITOR, LISINOPRIL, HYDROCHLOROTHIAZDE. Patient died on 08/06/2007.

Ontak Side Effects Report #5586199-2
Ontak side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2007. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: back pain , bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, pain in extremity, pain in jaw, sinus tachycardia. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 12/19/2007.


Ontak Side Effects Report #5599265-2
Ontak side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, sinus tachycardia, unresponsive to stimuli. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.

Ontak Side Effects Report #5663755-4
Ontak side effect was reported by a Physician from UNITED STATES on Feb 28, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: asthenia, bradycardia, cardio-respiratory arrest, cardiomegaly, dyspnoea, electromechanical dissociation, malaise, nausea , pain . Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.

Ontak Side Effects Report #5717053-0
Ontak side effect was reported by a Physician from UNITED STATES on Apr 09, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: abdominal hernia, arthralgia, asthenia, back pain , bradycardia, cardiac arrest , cardio-respiratory arrest, cardiomegaly, dyspnoea. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.